Riskpilot← Back to searchSign inGet full accessSANDSLI FYSIOTERAPI AS
ASActiveOrg 919295899Sandslihaugen 1, 5254 SandsliPhysiotherapy activities · NACE 8695Est. 20172 employees
Revenue 2024
NOK 1,7M
+8% vs 2023
EBITDA margin
-1.1%
+65% vs 2023
Equity ratio
31.5%
Financial strength
Net profit 2024
NOK -43K
+25% vs 2023
| Revenue | NOK 1,7M | +8% |
| EBITDA | NOK -20K | +65% |
| Net profit | NOK -43K | +25% |
| Total assets | NOK 330K | -20% |
| Equity | NOK 104K | -29% |
| Employees | 2 | — |
Legal name
SANDSLI FYSIOTERAPI AS
Org number
919295899
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
13. juli 2017
Share capital
NOK 49 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Fysioterapivirksomhet. Det skal i størst mulig utstrekning tilstrebes et faglig samarbeid for både å yte pasienten best mulig tjenester og sikre faglig utvikling, samt legge til rette for en tilfredsstillende økonomi for den enkelte fysioterapeut.
Address
Sandslihaugen 1, 5254 Sandsli
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 501 | 1 663 | 1 600 | 1 621 | 1 748 |
| Staff expenses | −121 | −133 | −147 | −145 | −185 |
| EBITDA | 48 | 68 | −78 | −56 | −20 |
| Depreciation & amort. | −4 | −0 | −0 | −2 | −24 |
| EBIT | 44 | 68 | −78 | −58 | −44 |
| Net financials | −0 | 0 | −25 | 1 | 1 |
| Profit before tax | 44 | 68 | −102 | −58 | −43 |
| Tax | 8 | 17 | −0 | −0 | −0 |
| Net profit | 36 | 51 | −102 | −58 | −43 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 434 | 487 | 408 | 414 | 330 |
| Equity | 257 | 307 | 205 | 147 | 104 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 177 | 180 | 203 | 266 | 226 |
| Total debt | 177 | 180 | 203 | 266 | 226 |
EBITDA margin
-1.1%
This company
15.8%
Market median
-107% vs market
20202024
Equity ratio
31.5%
This company
38.2%
Market median
+18% vs market
20202024
Return on equity
-41.8%
This company
18.4%
Market median
-327% vs market
20202024
Net profit margin
-2.5%
This company
8.1%
Market median
-131% vs market
20202024
Asset turnover
5.30×
This company
1.12×
Market median
+373% vs market
20202024
Debt / equity
2.18×
This company
0.62×
Market median
-252% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2017 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 14.29% | 14.29% | 2022 | |
| Individual | 14.29% | 14.29% | 2022 | |
| Individual | 14.29% | 14.29% | 2022 | |
| Individual | 14.29% | 14.29% | 2022 | |
| Individual | 14.29% | 14.29% | 2022 | |
| Individual | 14.29% | 14.29% | 2022 | |
| Individual | 14.29% | 14.29% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SANDSLI FYSIOTERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Vidar Van Gool | Board of Directors | 0 companies |